Journal Article10.1016/S0022-5347(01)61700-2
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
Anthony V. D'Amico,R. Whittington,S.B. Malkowicz,Daniel Schultz,Kenneth R. Blank,Gregory A. Broderick,John E. Tomaszewski,Andrew A. Renshaw,Irving D. Kaplan,Clair J. Beard,Alan J. Wein +10 more
TL;DR: Low-risk patients had estimates of 5-year PSA outcome after treatment with RP, RT, or implant with or without neoadjuvant androgen deprivation that were not statistically different, whereas intermediate- and high- risk patients treated with RP or RT did better then those treated by implant.
read more
About: This article is published in The Journal of Urology. The article was published on 01 Apr 1999. The article focuses on the topics: PSA Failure & Prostate cancer.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Identification of pathologically insignificant prostate cancer is not accurate in unscreened men.
Greg Shaw,Benjamin Thomas,Sarah Dawson,G Srivastava,Sarah L. Vowler,Vincent Gnanapragasam,Nimish Shah,Anne Y. Warren,David E. Neal +8 more
TL;DR: In the unscreened population, tools designed to identify insignificant PC are inaccurate, and Detection of a wider size range of prostate tumours in the un screened population may contribute to relative inaccuracy.
Comparative effectiveness of [(18) F]-fluorocholine PET-CT and pelvic MRI with diffusion-weighted imaging for staging in patients with high-risk prostate cancer.
Jean-Baptiste Pinaquy,Henri de Clermont-Galleran,Gilles Pasticier,G. Rigou,Nicolas Alberti,Elif Hindié,Yacoub Mokrane,Philippe Fernandez +7 more
TL;DR: The purpose of this study was to prospectively compare the diagnostic performance of 18F‐FCholine and MRI with diffusion weighted imaging (DWIMRI) for local and regional lymph node (LN) staging before radical prostatectomy (RP) with extended pelvic lymphadenectomy (PLND).
66
Endoglin (CD105) as a urinary and serum marker of prostate cancer.
Kazutoshi Fujita,Charles M. Ewing,David Y.S. Chan,Leslie A. Mangold,Alan W. Partin,William B. Isaacs,Christian P. Pavlovich,Christian P. Pavlovich +7 more
TL;DR: Elevations in post‐DRE urinary endoglin suggest there may be value in further studying endoglins as a urinary biomarker of prostate cancer, which may aid in prostate cancer detection and prognostication.
The current and potential role of cryoablation as a primary therapy for localized prostate cancer.
Aaron E. Katz,John C. Rewcastle +1 more
TL;DR: Cryoablation is an effective therapy with acceptable morbidity that should be offered as a treatment option to all patients with localized prostate cancer and has the potential ability to be tailored to an individual patient’s disease.
65
Highly Effective Radioisotope Cancer Therapy with a Non-Therapeutic Isotope Delivered and Sensitized by Nanoscale Coordination Polymers
Yu Chao,Chao Liang,Yu Yang,Guanglin Wang,Debabrata Maiti,Longlong Tian,Fei Wang,Wei Pan,Song Wu,Kai Yang,Zhuang Liu +10 more
TL;DR: This work presents a potential concept for the realization of highly effective cancer treatment with 99mTc, a short-half-life (6.0 h) diagnostic radioisotope, which is promising for cancer RIT with enhanced efficacy and reduced side effects.
65
References
Nonparametric Estimation from Incomplete Observations
Edward L. Kaplan,Paul Meier +1 more
TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
Regression Models and Life-Tables
TL;DR: The analysis of censored failure times is considered in this paper, where the hazard function is taken to be a function of the explanatory variables and unknown regression coefficients multiplied by an arbitrary and unknown function of time.
28.6K
Results of Conservative Management of Clinically Localized Prostate Cancer
Gerald W. Chodak,Ronald A. Thisted,Glenn S. Gerber,Jan-Erik Johansson,Jan Adolfsson,George W. Jones,Geoff D. Chisholm,Boaz Moskovitz,Pinhas M. Livne,John J. Warner +9 more
TL;DR: The strategy of initial conservative management and delayed hormone therapy is a reasonable choice for some men with grade 1 or 2 clinically localized prostate cancer, particularly for those who have an average life expectancy of 10 years or less.
913
Prostate Specific Antigen Based Disease Control Following Ultrasound Guided sup 125 Iodine Implantation for Stage T1/T2 Prostatic Carcinoma
TL;DR: There is a high rate of clinical and chemical freedom from progression following 125I implantation for select patients with early stage prostatic carcinoma.
274
Related Papers (5)
Nicolas Mottet,Joaquim Bellmunt,Michel Bolla,Erik Briers,Marcus G. Cumberbatch,Maria De Santis,Nicola Fossati,Tobias Gross,Ann Henry,Steven Joniau,Thomas B. Lam,Thomas B. Lam,Malcolm David Mason,Vsevolod Matveev,Paul C. Moldovan,Roderick C.N. van den Bergh,Thomas Van den Broeck,Henk G. van der Poel,Theo H. van der Kwast,Olivier Rouvière,Ivo G. Schoots,Thomas Wiegel,Philip Cornford +22 more
Geert J.L.H. van Leenders,Theodorus van der Kwast,David J. Grignon,Andrew Evans,Glen Kristiansen,Charlotte F. Kweldam,Geert Litjens,Jesse K. McKenney,Jonathan Melamed,N. Mottet,Gladell P. Paner,Hemamali Samaratunga,Ivo G. Schoots,Jeffry P. Simko,Toyonori Tsuzuki,Murali Varma,Anne Y. Warren,Thomas M. Wheeler,Sean R. Williamson,Kenneth A. Iczkowski +19 more